Download PDF
Aktuelle Rheumatologie 2019; 44(02): e2
DOI: 10.1055/a-0868-9915
Erratum
Georg Thieme Verlag KG Stuttgart · New York

Correction: B-Cell-Attracting Chemokine CXCL13 As a Marker of Disease Activity in Systemic Lupus Erythematosus (SLE)

Erratum: B-Cell-anziehendes Chemokin CXCL13 als Marker der Krankheitsaktivität im Systemischen Lupus Erythematodes (SLE)
Eman Ahmed Hamed Omran
1   Rheumatology, Rehabilitation, and Physical Medicine Department, Faculty of Medicine, Assiut University, Assiut, Egypt
,
Eman H. El-Hakeim
1   Rheumatology, Rehabilitation, and Physical Medicine Department, Faculty of Medicine, Assiut University, Assiut, Egypt
,
Marwa A. A. Galal
1   Rheumatology, Rehabilitation, and Physical Medicine Department, Faculty of Medicine, Assiut University, Assiut, Egypt
,
Nada M. M. Nasr
2   Rheumatology, Om El Qusour Hospital, Rehabilitation, Assiut, Egypt
,
Eman Mosaad
3   South Egypt Cancer Institute, Clinical Pathology, Assiut, Egypt
› Author Affiliations
Further Information

Publication History

Publication Date:
20 March 2019 (online)

Also available at
    Permissions and Reprints

Correction to:

B-Cell-Attracting Chemokine CXCL13 As a Marker of Disease Activity in Systemic Lupus Erythematosus (SLE)Aktuelle Rheumatologie 2019; 44(02): 115-120
DOI: 10.1055/s-0043-121875

Erratum

B-Cell-Attracting Chemokine CXCL13 As a Marker of Disease Activity in Systemic Lupus Erythematosus (SLE)

B-Cell-anziehendes Chemokin CXCL13 als Mar ker der Krankheitsaktivität im Systemischen Lupus Erythematodes (SLE)

Omran EAH, El-Hakeim EH, Galal MAA, et al.

Akt Rheumatol DOI: 10.1055/s-0043-121875

[Epub ahead of print]

Im oben genannten Artikel wurde der englische Titel falsch ins Deutsche übersetzt. Richtig ist: B-Cell-anziehendes Chemokin CXCL13 als Marker der Krankheitsaktivität im Systemischen Lupus Erythematodes (SLE).